Search

everythinglearnresearchcommunity

for

Search:↓

A woman's vitiligo improved with tofacitinib treatment, and her skin color remained even after stopping the medication, but there are concerns about cancer risk.

Frontal Fibrosing Alopecia needs better diagnostics and treatments, with dutasteride showing promise.

Tofacitinib is a potential alternative treatment for alopecia totalis, especially in patients with a shorter duration of the condition and more preserved hair follicles, but the overall response rate is low.

The best treatment for Frontal Fibrosing Alopecia and Lichen Planopilaris combines oral and topical medications to reduce symptoms and stop hair loss.

Finasteride helps female-pattern hair loss.

JAK inhibitors may help treat alopecia areata and promote hair regrowth.

Abrocitinib, a JAK inhibitor, may help treat atopic dermatitis and alopecia universalis together.

A new mutation in the TMEM173 gene and a risk allele in IFIH1 cause a unique set of immune-related symptoms.

Baricitinib helped improve hair, eyebrow, and eyelash growth in alopecia areata patients.

Baricitinib for severe alopecia areata is generally safe, with common side effects like infections and acne, and low rates of serious complications.

Baricitinib was effective in regrowing hair in patients with different levels of alopecia areata severity.

Baricitinib was more effective than a placebo in regrowing hair in adults with alopecia areata after 36 weeks.

Baricitinib helps grow eyebrows and eyelashes in severe alopecia areata patients.

Baricitinib was effective in regrowing eyebrow and eyelash hair in patients with severe alopecia areata.

Most patients experienced mild to moderate skin problems during a trial for a desmoid tumor treatment.

Abrocitinib at 100 mg and 200 mg daily may significantly improve moderate-to-severe atopic dermatitis in patients 12 years and older.

Ruxolitinib effectively and safely regrows hair in alopecia patients.

Baricitinib helps with severe hair loss, negative-pressure therapy lowers hernia recurrence, tranexamic acid reduces bleeding, robot-assisted breast surgery may improve outcomes, and acellular dermal matrix could decrease breast reconstruction complications.

Tofacitinib may help regrow hair in severe alopecia areata, but results differ greatly between people.

Upadacitinib cleared scalp alopecia areata in three patients and also improved atopic dermatitis with minimal side effects.

A specific immune response helps control mite populations on the skin, maintaining healthy hair follicles.

Low dose methotrexate does not increase hair fall and may reduce it.

Methotrexate dose has little effect on its toxicity when used with adalimumab for early rheumatoid arthritis.

Upadacitinib significantly improved both rheumatoid arthritis and alopecia areata in a patient.

Ritlecitinib effectively treats alopecia areata in patients 12 and older with fewer side effects.

Enz_MoriL from mulberry leaves helps hair growth by affecting specific cell pathways.

Baricitinib at 2mg and 4mg doses improved work productivity and reduced costs for adults with atopic dermatitis.

Methotrexate is effective for treating rheumatoid arthritis but requires regular monitoring.

Intestinal intraepithelial lymphocytes are crucial for gut immunity and maintaining the mucosal barrier.

Using a combination of specific cell cycle regulators is better for safely keeping hair root cells alive indefinitely compared to cancer-related methods.